Context-Dependent miR-21 Regulation of TLR7-Mediated Autoimmune and Foreign Antigen-Driven Antibody-Forming Cell and Germinal Center Responses

MicroRNAs (miRNAs) are involved in healthy B cell responses and the loss of tolerance in systemic lupus erythematosus (SLE), although the role of many miRNAs remains poorly understood. Dampening miR-21 activity was previously shown to reduce splenomegaly and blood urea nitrogen levels in SLE-prone mice, but the detailed cellular responses and mechanism of action remains unexplored. In this study, using the TLR7 agonist, imiquimod-induced SLE model, we observed that loss of miR-21 in Sle1b mice prevented the formation of plasma cells and autoantibody-producing Ab-forming cells (AFCs) without a significant effect on the magnitude of the germinal center (GC) response. We further observed reduced dendritic cell and monocyte numbers in the spleens of miR-21-deficient Sle1b mice that were associated with reduced IFN, proinflammatory cytokines, and effector CD4⁺ T cell responses. RNA sequencing analysis on B cells from miR-21-deficient Sle1b mice revealed reduced activation and response to IFN, and cytokine and target array analysis revealed modulation of numerous miR-21 target genes in response to TLR7 activation and type I IFN stimulation. Our findings in the B6.Sle1bYaa (Sle1b ^Yaa) spontaneous model recapitulated the miR-21 role in TLR7-induced responses with an additional role in autoimmune GC and T follicular helper responses. Finally, immunization with T-dependent Ag revealed a role for miR-21 in foreign Ag-driven GC and Ab, but not AFC, responses. Our data suggest a potential multifaceted, context-dependent role for miR-21 in autoimmune and foreign Ag-driven AFC and GC responses. Further study is warranted to delineate the cell-intrinsic requirements and mechanisms of miR-21 during infection and SLE development.

B-Cell-Intrinsic Type 1 Interferon Signaling Is Crucial for Loss of Tolerance and the Development of Autoreactive B Cells

Type 1 interferon (T1IFN) signaling promotes inflammation and lupus pathology, but its role in autoreactive B cell development in the antibody-forming cell (AFC) and germinal center (GC) pathways is unclear. Using a lupus model that allows for focused study of the AFC and GC responses, we show that T1IFN signaling is crucial for autoreactive B cell development in the AFC and GC pathways. Through bone marrow chimeras, DNA-reactive B cell transfer, and GC-specific Cre mice, we confirm that IFNαR signaling in B cells promotes autoreactive B cell development into both pathways. Transcriptomic analysis reveals gene expression alterations in multiple signaling pathways in non-GC and GC B cells in the absence of IFNαR. Finally, we find that T1IFN signaling promotes autoreactive B cell development in the AFC and GC pathways by regulating BCR signaling. These data suggest value for anti-IFNαR therapy in individuals with elevated T1IFN activity before clinical disease onset.

The B-cell-intrinsic mechanisms of type 1 interferon (T1IFN) signaling in regulating B cell tolerance is unclear. Domeier et al. show that T1IFN signaling in B cells causes loss of B cell tolerance, promoting autoreactive B cell development into the antibody-forming cell and germinal center pathways by regulating BCR signaling.

Selenium supplementation suppresses immunological and serological features of lupus in B6.Sle1b mice

Systemic lupus erythematosus (SLE) is a debilitating multi-factorial immunological disorder characterized by increased inflammation and development of anti-nuclear autoantibodies. Selenium (Se) is an essential trace element with beneficial anti-cancer and anti-inflammatory immunological functions. In our previous proteomics study, analysis of Se-responsive markers in the circulation of Se-supplemented healthy men showed a significant increase in complement proteins. Additionally, Se supplementation prolonged the life span of lupus prone NZB/NZW-F1 mice. To better understand the protective immunological role of Se in SLE pathogenesis, we have investigated the impact of Se on B cells and macrophages using in vitro Se supplementation assays and the B6.Sle1b mouse model of lupus with an oral Se or placebo supplementation regimen. Analysis of Se-treated B6.Sle1b mice showed reduced splenomegaly and splenic cellularity compared to untreated B6. Sle1b mice. A significant reduction in total B cells and notably germinal center (GC) B cell numbers was observed. However, other cell types including T cells, Tregs, DCs and pDCs were unaffected. Consistent with reduced GC B cells there was a significant reduction in autoantibodies to dsDNA and SmRNP of the IgG2b and IgG2c subclass upon Se supplementation. We found that increased Se availability leads to impaired differentiation and maturation of macrophages from mouse bone marrow derived progenitors in vitro. Additionally, Se treatment during in vitro activation of B cells with anti-CD40L and LPS inhibited optimal B cell activation. Overall our data indicate that Se supplementation inhibits activation, differentiation and maturation of B cells and macrophages. Its specific inhibitory effect on B cell activation and GC B cell differentiation could be explored as a potential therapeutic supplement for SLE patients.

Crucial role of Mer tyrosine kinase in the maintenance of SIGN-R1+ marginal zone macrophages

Mer Tyrosine Kinase receptor (Mer) is involved in anti-inflammatory efferocytosis. Here we report elevated spontaneous germinal center (Spt-GC) responses in Mer-deficient mice (Mer^-/- ) that are associated with the loss of SIGN-R1⁺ marginal zone macrophages (MZMs). The dissipation of MZMs in Mer^-/- mice occurs independently of reduced cellularity or delocalization of marginal zone B cells, sinusoidal cells or of CD169⁺ metallophillic macrophages. We find that MZM dissipation in Mer^-/- mice contributes to apoptotic cell (AC) accumulation in Spt-GCs and dysregulation of the GC checkpoint, allowing an expansion of DNA-reactive B cells in GCs. We further observe that bone marrow derived macrophages from Mer^-/- mice produce more TNFα, and are susceptible to cell death upon exposure to ACs compared to WT macrophages. Anti-TNFα Ab treatment of Mer^-/- mice is, however, unable to reverse MZM loss, but results in reduced Spt-GC responses, indicating that TNFα promotes Spt-GC responses in Mer^-/- mice. Contrary to an anti-TNFα Ab treatment, treatment of Mer^-/- mice with a synthetic agonist for the transcription factor LXRα rescues a significant number of MZMs in vivo. Our data suggest that Mer-LXRα signaling plays an important role in the differentiation and maintenance of MZMs, which in turn regulate Spt-GC responses and tolerance.

Reciprocal regulation of germinal center and regulatory B cell responses by IFNγ receptor-STAT1 signaling in TLR7 mediated autoimmunity

Toll like receptor 7 (TLR7) plays a critical role in systemic autoimmunity. The mechanisms that fine-tune germinal center versus regulatory B cell response in TLR7 mediated autoimmunity remain unclear. Regulatory B cells that produce IL-10 (B10 cells) negatively regulate autoimmunity and infections. We report that TLR7 deficiency in non-autoimmune B6 and autoimmune prone B6.Sle1b mice showed increased IL-10 producing B10 cells. In contrast, B6.Yaa and B6.Sle1b.Yaa mice expressing an extra copy of TLR7 in the Yaa locus showed decreased percentage of B10 cells. TLR7 deficiency in B cells inhibited whereas an extra copy of TLR7 enhanced proliferation and cytokine expression of cocultured antigen specific CD4 T cells. Interestingly, B10 cells displayed highest IFNγR expression compared to other subsets of T and B cells. Whereas B6.Sle1b.Yaa mice lacked B10 cells and marginal zone compartment (MZ), B6.Sle1b.Yaa mice deficient in IFNγR (B6.Sle1b.Yaa/IFNγR−/−) restored these populations. Further, B6.Sle1b.Yaa/IFNγR−/− mice showed diminished spontaneous germinal center (Spt-GC) and serum autoantibody responses, and renal pathology compared to B6.Sle1b.Yaa control mice. Similar results were observed when B6.Sle1b and B6.Sle1b.IFNγR−/− mice were treated with TLR7 ligand, imiquimod. B10 and GC B cells exhibited higher STAT1 and T-bet expression than follicular B cells. Mice deficient in STAT1 and T-bet had significantly reduced GC and IgG2c Ab responses while retained intact B10 and MZ compartments upon imiquimod treatment, contrary to what was observed in wild type mice. Together, these data define the critical differential role of IFNγR, STAT1, and T-bet in GC B cell and B10 cell development in TLR7 mediated autoimmunity.

Model specific role of B cell-intrinsic IFNαR signaling in promoting spontaneous germinal centers and autoimmunity

In systemic lupus erythematosus (SLE), germinal centers can form spontaneously (Spt-GCs) in the absence of foreign antigen and drive high-affinity autoantibody (autoAb) production. Overexpression of Type 1 interferon (IFNα) accelerates autoimmunity and alters B cell selection in certain SLE mouse models, but in another model, B cell intrinsic IFNαR signaling is shown to be dispensable for autoimmune GC response and autoimmunity. Using B6.Sle1b autoimmune mice derived from the NZM2410 SLE mouse model, we show here that IFNαR signaling is not required for Spt-GC formation but is important for elevated Spt-GC response and autoreactive B cell selection into AFCs. IFNα receptor1 deficient B6.Sle1b mice (B6.Sle1b.IFNαR1−/−) have lower Spt-GC and Tfh responses, reduced CD86 expression on B cells and diminished autoAb titers as compared to B6.Sle1b mice. We also observe lower Ca2+ flux in B cells deficient in IFNα receptor compared to control B cells upon BCR cross-linking in vitro. Consistently, we find that B cell-intrinsic IFNαR signaling promotes differentiation of Sle1b-expressing DNA-reactive B cells into GC B cells. RNA sequencing studies show that B6.Sle1b and B6.Sle1b.IFNαR1−/− GC B cells have distinct transcriptional profiles that are associated with proliferation, cell survival, and antigen presentation pathways. Compared to B6.Sle1b control, B6.Sle1b.IFNαR1−/− B cells fail to form stable conjugates with T cells in vitro and GC B cells express reduced levels of ICOS-ligand in vivo, suggesting B6.Sle1b.IFNαR1−/− B cells may not acquire adequate T cell help. These data reveal novel information about the model specific role of B cell-intrinsic IFNαR signaling in the regulation of Spt-GCs and autoimmunity.

Mer receptor tyrosine kinase signaling prevents TLR-mediated self-ligand sensing and aberrant selection in germinal centers

Mer receptor tyrosine kinase (Mer) signaling maintains immune tolerance by clearing apoptotic cells and inducing immunoregulatory signaling cascades. We previously showed that Mer-deficient mice on a mixed B6 and 129 background (B6129F2.Mer−/−) have increased germinal center (GC) responses, T cell activation, and apoptotic cell accumulation within GCs. Whereas B6129F2.Mer−/− mice accumulate apoptotic cells in GCs, B6.Mer−/− mice do not accumulate apoptotic cells, resembling B6 mice. Therefore, we used these two models to mechanistically separate the effects of debris released from secondary necrotic cells as a result of apoptotic cell accumulation from those driven by the loss of immune regulation by Mer. Through the study of global and cell-type intrinsic TLR and MyD88 deficiency in B6129F2.Mer−/− mice, we found that GC B cell-intrinsic sensing of self-RNA, but not self-DNA, released from secondary necrotic cells drives self-antigen induced GC responses. While self-ligands drive the magnitude of GC response, the loss of Mer immunoregulatory signaling bolsters antigen presentation and APC-intrinsic TLR activation drives pro-inflammatory cytokine production. Further, the loss of Mer immunoregulatory signaling accelerates the onset of autoimmunity when B6.Mer−/− mice are crossed to autoimmune-prone B6.Sle1b mice (Sle1b.Mer−/−) due to the retention of autoreactive B cells in GCs. Collectively, Mer prevents the cell-intrinsic activation of GC B cells and APCs to regulate the magnitude of GC response and T cell activation, in addition to regulating GC selection events to prevent the development of autoimmunity.